Fresenius Sells 13.4 Million Medical Care Shares, Raising €524 Million

Fresenius SE & Co. KGaA has successfully sold 13.4 million shares of Fresenius Medical Care AG at €39.00 each, generating gross proceeds of approximately €524 million. This transaction lowers Fresenius's stake in Fresenius Medical Care from around 25% to approximately 20% since its deconsolidation, down from 32%, for total proceeds of roughly €2.3 billion.

The company plans to utilize the funds in line with its capital allocation strategies under the #FutureFresenius initiative, aiming to invest in growth platforms. Fresenius CFO Sara Hennicken emphasized that this move aligns with the strategic priorities set in the REJUVENATE phase. The book gain from this sale is anticipated to appear in Q4 2026 results.

The share sale was conducted as an accelerated bookbuild offering to institutional investors, with major financial institutions acting as Joint Bookrunners. Settlement is expected by November 16, 2026.